Dr. Michael Rosol joins staff as Senior Director of Business Development

May 1, 2016

Michael Rosol, Ph.D., Senior Director of Business Development

 

Dr. Rosol is a biomedical imaging professional with extensive commercial experience, notably in his prior position as Head of the Translational Imaging Group at Novartis Pharmaceuticals, which provides him with deep insights into the needs of industry for the development, validation, and implementation of imaging biomarkers in clinical trials. Dr. Rosol’s scientific background qualifies him to position the highly scientific nature of Elucid’s product line with clarity to strategic partners and early customers. His training and experience lie in the fields of biophysics, physiology, and biological/medical imaging, and his work has focused on cardiovascular imaging, preclinical and clinical imaging instrumentation and applications, animal models of human disease, pathophysiology, biomarkers, and imaging in toxicological and clinical trials. He has also been faculty in Radiology and director of two academic research imaging facilities, fitting the profile of those with specific interest to move the field forward. At Elucid, he will leverage his expansive network of connections to drive adoption of our CAP applications.